merged_africa-snakebite-treatment-access.txt


<question_number>1</question_number>
<answer>N/A</answer>
<question_number>2</question_number>
<answer>Indian antivenom is formulated for kraits, while Kenyan puff adders have distinct venom toxins not neutralized by Indian products.</answer>
<question_number>3</question_number>
<answer>Neurotoxins from cobras/mambas and hemotoxins from puff adders require simultaneous targeting for universal efficacy.</answer>
<question_number>4</question_number>
<answer>Spitting cobra venom causes severe ocular damage mistaken for non-venomous injuries, compounded by reliance on traditional healers.</answer>
<question_number>5</question_number>
<answer>Rainy season flooding and dry season food/water searches increase snake encounters, disproportionately affecting farmers and rural dwellers.</answer>
<question_number>6</question_number>
<answer>Black mambas' neurotoxins act rapidly, while puff adders' hemotoxins cause slower, tissue-destructive effects despite higher venom volume.</answer>
<question_number>7</question_number>
<answer>Antivenom's cold-storage requirements clash with Kenya's infrastructure, delaying treatment and worsening outcomes for pregnant victims.</answer>
<question_number>8</question_number>
<answer>Tourniquets and traditional treatments exacerbate tissue damage and delay antivenom administration, worsening outcomes despite initial intent to mitigate venom spread.</answer>